My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone (HGH)
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Livewell Pharmaceuticals Livewell Pharmaceuticals
PT-141
PT-141 - Livewell Pharmaceuticals

PT-141 - Livewell Pharmaceuticals

Brand:
Livewell Pharmaceuticals
Category:
Peptides
Substance:
Bremelanotide (PT-141)
Package:
10 mg
Price:
£52.00 - £52.00
See options
Product Overview
Bremelanotide, also known as PT-141, is a melanocortin receptor agonist approved by the FDA in 2019 under the brand name Vyleesi for treating hypoactive sexual desire disorder (HSDD) in premenopausal women. Unlike flibanserin, it acts by stimulating melanocortin 1 and 4 receptors in the hypothalamus, which modulate sexual arousal through dopamine release. Though its exact mechanism isn’t fully known, it enhances excitatory pathways in sexual response. It is administered at least 45 minutes before sexual activity and improves desire and reduces distress in HSDD.
References:

Hall, K. S. K., & Binik, Y. M. (2020). Principles and practice of sex therapy (6th ed.). The Guilford Press.

Paauw, D. (2024). Newer outpatient therapies and treatments, an issue of Medical Clinics of North America. Elsevier.

Stahl, S.M., 2020. Prescriber's Guide: Stahl's Essential Psychopharmacology. United Kingdom: Cambridge University Press.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about PT-141 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.

Products
Active Substances
  • Bremelanotide (PT-141)
 About Product
PT-141(Bremelanotide)
Livewell Pharmaceuticals
USA
£52.00
Show more
Reviews
Leave Review
FAQ
What is Bremelanotide used for?
It is prescribed for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
References:

Hall, K. S. K., & Binik, Y. M. (2020). Principles and practice of sex therapy (6th ed.). The Guilford Press.

Paauw, D. (2024). Newer outpatient therapies and treatments, an issue of Medical Clinics of North America. Elsevier.

Stahl, S.M., 2020. Prescriber's Guide: Stahl's Essential Psychopharmacology. United Kingdom: Cambridge University Press.

How does it work?
Bremelanotide activates melanocortin 1 and 4 receptors in the hypothalamus, leading to dopamine release and increased sexual desire.
References:

Hall, K. S. K., & Binik, Y. M. (2020). Principles and practice of sex therapy (6th ed.). The Guilford Press.

Paauw, D. (2024). Newer outpatient therapies and treatments, an issue of Medical Clinics of North America. Elsevier.

Stahl, S.M., 2020. Prescriber's Guide: Stahl's Essential Psychopharmacology. United Kingdom: Cambridge University Press.

When should it be taken?
It should be used at least 45 minutes before anticipated sexual activity.
References:

Hall, K. S. K., & Binik, Y. M. (2020). Principles and practice of sex therapy (6th ed.). The Guilford Press.

Paauw, D. (2024). Newer outpatient therapies and treatments, an issue of Medical Clinics of North America. Elsevier.

Stahl, S.M., 2020. Prescriber's Guide: Stahl's Essential Psychopharmacology. United Kingdom: Cambridge University Press.